Evoke Wealth, LLC Moderna, Inc. Transaction History

Evoke Wealth, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$118.07 - $194.18 $14,168 - $23,301	120 Added 100.84%	239 $28,000
Q2 2022 Aug 04, 2022	SELL	$117.13 - $176.59 $4,919 - $7,416	-42 Reduced 26.09%	119 $17,000
Q1 2022 May 10, 2022	BUY	$126.46 - $235.05 $3,035 - $5,641	24 Added 17.52%	161 $28,000
Q4 2021 Feb 09, 2022	BUY	$225.82 - $368.51 $8,129 - $13,266	36 Added 35.64%	137 $35,000
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $3,328 - $7,267	15 Added 17.44%	101 $38,000
Q2 2021 Aug 05, 2021	SELL	$129.91 - $234.98 $8,184 - $14,803	-63 Reduced 42.28%	86 $20,000
Q1 2021 May 13, 2021	BUY	$109.18 - $185.98 $9,607 - $16,366	88 Added 144.26%	149 $20,000
Q2 2020 Aug 10, 2020	SELL	$29.67 - $80.0 $29,670 - $80,000	-1,000 Reduced 94.25%	61 $4,000
Q1 2020 May 07, 2020	BUY	$17.78 - $31.58 $1,084 - $1,926	61 Added 6.1%	1,061 $31.8 Million
Q3 2019 Nov 12, 2019	BUY	$12.26 - $18.07 $12,260 - $18,070	1,000 New	1,000 $15.9 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Evoke Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Evoke Wealth, LLC with notifications on news.